PHXC mRNA — Drug Target
All drugs that target PHXC mRNA — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- DCR-PHXC · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · RNA interference therapeutic · Genetic/Metabolic Disease
DCR-PHXC is an RNA interference therapeutic that silences the PHXC gene to reduce production of a disease-causing protein.